PlainRecalls
FDA Drug Moderate Class II Terminated

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

Reported: January 9, 2013 Initiated: December 4, 2012 #D-107-2013

Product Description

Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.

Reason for Recall

Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.

Details

Recalling Firm
Abbott Laboratories
Units Affected
28, 524 bottles
Distribution
US Nationwide and Puerto Rico
Location
Abbott Park, IL

Frequently Asked Questions

What product was recalled?
Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; ABBOTT LABORATORIES NORTH CHICAGO, IL 60064 U.S.A.. Recalled by Abbott Laboratories. Units affected: 28, 524 bottles.
Why was this product recalled?
Labeling: Error on Declared Strength. Product labeled to contain 150 mcg tablets actually contained 75 mcg tablets.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 9, 2013. Severity: Moderate. Recall number: D-107-2013.